Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$328K Hold
6,261
0.11% 132
2026
Q1
$346K Hold
6,261
0.13% 100
2025
Q4
$307K Hold
6,261
0.11% 116
2025
Q3
$270K Sell
6,261
-42
-0.7% -$1.64K 0.1% 133
2025
Q2
$242K Buy
6,303
+620
+11% +$23.7K 0.1% 151
2025
Q1
$220K Buy
+5,683
New +$208K 0.11% 152
2024
Q4
Sell
-6,742
Closed -$276K 187
2024
Q3
$276K Sell
6,742
-1,224
-15% -$50.1K 0.13% 133
2024
Q2
$307K Buy
+7,966
New +$335K 0.16% 108
2023
Q1
Sell
-5,846
Closed -$205K 158
2022
Q4
$205K Buy
+5,846
New +$195K 0.14% 135
2022
Q3
Sell
-5,393
Closed -$293K 138
2022
Q2
$293K Buy
+5,393
New +$298K 0.22% 90

Other funds holding GSK

Five Oceans Advisors's GSK Position: Q2 2026 in Review

Five Oceans Advisors held its GSK (GSK) position steady in Q2 2026 at 6,261 shares worth $328K. The position accounts for 0.11% of the portfolio, ranked #132.

Five Oceans Advisors first reported a position in GSK in Q2 2022 and has held it in 10 quarters since. The position peaked at $346K in Q1 2026. 161 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Five Oceans Advisors held 6,261 shares of GSK worth $328K as of Q2 2026.
  • Five Oceans Advisors left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.11% of Five Oceans Advisors's portfolio in Q2 2026, its #132 holding.
  • Five Oceans Advisors first reported a position in GSK in Q2 2022 and has held it in 10 quarters since.
  • Five Oceans Advisors's GSK position peaked at $346K in Q1 2026.
  • 161 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Five Oceans Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.